Published 22 days ago

Psychedelic drug MDMA faces questions as FDA considers approval for PTSD

The first new PTSD drug in over 20 years, a version of MDMA by Lykos Therapeutics Inc., is up for approval. Federal regulators must approve the mind-altering drug, also known as ecstasy.
Lykos Therapeutics Inc., a nonprofit-backed drugmaker, aims to bring psychedelic therapy to the masses with the new PTSD drug based on MDMA.
FDA scientists noted significant and lasting PTSD symptom improvements in patients who received MDMA alongside talk therapy, prompting questions about the drug's safety and efficacy.

Insights by Ground AI

Does this summary seem wrong?

0 Articles

All

Left

Center

Right

The Independent

The battle for MDMA as drug steps closer to becoming a prescription medicine

MDMA could be reclassified as a prescription medicine and made available to specially certified doctors and therapists

22 days ago·London, United Kingdom

Read Full Article

Associated Press News

Psychedelic drug MDMA faces questions as FDA considers approval for PTSD

WASHINGTON (AP) — Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates to move psychedelic drugs into the medical mainstream.The Food and Drug Administration posted its initial review of the drug Friday,...

22 days ago·United States

Read Full Article

abc News

Psychedelic drug MDMA faces questions as FDA considers approval for PTSD

Federal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD

22 days ago·United States

Read Full Article

KIFI

Psychedelic drug MDMA faces questions as FDA considers approval for PTSD

By MATTHEW PERRONE AP Health Writer WASHINGTON (AP) — Federal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD. The Food and Drug Administration posted its review of the drug on Friday, raising questions about its effectiveness and potential risks, including heart problems. The drug application is part of a decadeslong effort by advocates to move psychedelic drugs into the …

22 days ago·Idaho Falls, United States

Read Full Article

CBS News

Psychoactive drugs like ketamine and MDMA are having a moment. The FDA will soon weigh in.

Drugs such as LSD, ketamine, mushrooms and MDMA can be powerful treatments for severe depression and PTSD, mounting evidence suggests — but not everyone is convinced.

26 days ago

Read Full Article

Winnipeg Free Press

Psychedelic drug MDMA faces questions as FDA considers approval for PTSD

WASHINGTON (AP) — Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of […]

23 days ago·Winnipeg, Canada

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year